Kupffer cells ameliorate hepatic insulin resistance induced by high-fat diet rich in monounsaturated fatty acids: the evidence for the involvement of alternatively activated macrophages by Zuzana Papackova et al.
RESEARCH Open Access
Kupffer cells ameliorate hepatic insulin resistance
induced by high-fat diet rich in monounsaturated
fatty acids: the evidence for the involvement of
alternatively activated macrophages
Zuzana Papackova1, Eliska Palenickova1, Helena Dankova1, Jana Zdychova1, Vojtech Skop2, Ludmila Kazdova1 and
Monika Cahova1*
Abstract
Background: Resident macrophages (Kupffer cells, KCs) in the liver can undergo both pro- or anti-inflammatory
activation pathway and exert either beneficiary or detrimental effects on liver metabolism. Until now, their role in
the metabolically dysfunctional state of steatosis remains enigmatic. Aim of our study was to characterize the role
of KCs in relation to the onset of hepatic insulin resistance induced by a high-fat (HF) diet rich in monounsaturated
fatty acids.
Methods: Male Wistar rats were fed either standard (SD) or high-fat (HF) diet for 4 weeks. Half of the animals were
subjected to the acute GdCl3 treatment 24 and 72 hrs prior to the end of the experiment in order to induce the
reduction of KCs population. We determined the effect of HF diet on activation status of liver macrophages and on
the changes in hepatic insulin sensitivity and triacylglycerol metabolism imposed by acute KCs depletion by GdCl3.
Results: We found that a HF diet rich in MUFA itself triggers an alternative but not the classical activation program
in KCs. In a steatotic, but not in normal liver, a reduction of the KCs population was associated with a decrease of
alternative activation and with a shift towards the expression of pro-inflammatory activation markers, with the
increased autophagy, elevated lysosomal lipolysis, increased formation of DAG, PKCε activation and marked
exacerbation of HF diet-induced hepatic insulin resistance.
Conclusions: We propose that in the presence of a high MUFA content the population of alternatively activated
resident liver macrophages may mediate beneficial effects on liver insulin sensitivity and alleviate the metabolic
disturbances imposed by HF diet feeding and steatosis. Our data indicate that macrophage polarization towards an
alternative state might be a useful strategy for treating type 2 diabetes.
Obesity and type 2 diabetes have reached epidemic pro-
portions in most of the Western world. Both conditions
are strongly associated with non-alcoholic fatty liver dis-
ease (NAFLD) [1]. Obesity was first recognized as a
chronic low-grade inflammatory condition of adipose
tissue more than a decade ago [2]. Both liver and adi-
pose tissue possess a specific macrophage subpopulation
-"resident macrophages"- that undergo local activation
in response to various stimuli and express distinct pat-
terns of surface markers, chemokines and cytokines [3].
Depending on the triggering stimuli and genetic back-
ground, macrophages can undergo either a “classical”
(Th1 dependent; M1) or “alternative” (Th2 dependent;
M2) activation pathway. M1 response is an essential
part of innate immunity and this pro-inflammatory pro-
gram serves to protect the host against invading patho-
gens. However, if excessive, the inflammatory response
becomes detrimental [4]. Many studies have supported
the idea that inflammatory cytokine signaling directly
promotes insulin resistance [5]. An “alternative” (M2)
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activation pathway results in a protective phenotype - it
promotes maturation of alternatively activated macro-
phages to counteract excessive inflammation, enhance
tissue repair and may have a beneficial role in regulating
nutrient homeostasis [6].
Dietary fat intake has been long proposed as a causa-
tive factor for the development of metabolic syndrome.
In this regard, not only the quantity, but mainly the
quality of dietary fat consumed strongly predicts the
prevalence of insulin resistance, type 2 diabetes and
atherosclerosis [7,8]. Recent research suggests that most
of the pro-inflammatory response of the innate immune
system to invading pathogens can be traced to the
unique family of membrane receptors known as TLRs
[5]. Of great importance is the finding that TLRs (espe-
cially TLR2 and TLR4) recognize and are activated by
the saturated fatty acyl moieties of bacterial lipopolysac-
charide (LPS) while after substitution of saturated acyl
moiety with unsaturated fatty acid the activity of LPS is
lost [9,10]. The long experience, that diets enriched in
SFA have been associated with increased risk for insulin
resistance and type 2 diabetes [11] while dietary MUFA
are protective against metabolic syndrome and cardio-
vascular disease risk factors [12,13] is perfectly in line
with this finding.
An inflammatory response in the presence of obesity
appears to be triggered by, and to reside predominantly
in, adipose tissue [14]. In contrast to the adipose tissue,
the accumulation of triacylglycerol droplets within hepa-
tocytes (hepatic steatosis) is not generally associated
with inflammation [15]. KCs, the resident liver macro-
phages, are the largest macrophage population in the
body [16] and, in addition to fulfilling a variety of other
immunologic functions [17,18], are the primary innate
immune defense against exposure of foreign antigens
from the diet and intestinal tract [18,19]. KCs are
chronically exposed to higher concentrations of endo-
toxin than circulating peripheral blood monocytes.
Therefore, it seems plausible that protective mechanisms
have evolved to avoid the inadvertent activation of KCs
while maintaining scavenger function [20]. In this con-
nection, it is important to stress that resident hepatic
macrophages display tremendous plasticity in their acti-
vation programs, ranging from the pro-inflammatory
classical state to the anti-inflammatory alternative state
[21,22]. While the rapid onset of inflammation in adi-
pose tissue due to the HF diet feeding in adipose tissue
is well established, there are only a few studies addres-
sing the role of hepatic resident macrophages in the
inflammatory and metabolically dysfunctional obese
state and these studies have brought contradictory
results. Some authors provide evidence that KCs may, at
least partially, protect hepatocytes from the inflamma-
tory milieu and the insulin resistance associated with a
high-fat diet-induced obesity [6,23,24]. In contrast, other
reports showed that hepatic macrophage response parti-
cipates in the onset of high-fat diet-induced hepatic
insulin resistance [25,26].
The aim of our study was to characterize the role of
KCs in relation to the onset of hepatic insulin resistance
induced by a HF diet rich in MUFA. In order to address
this issue, we determined the effect of HF diet on the
activation status of liver macrophages and the changes
in hepatic insulin sensitivity and hepatic TAG metabo-
lism imposed by acute KCs depletion by GdCl3, a speci-
fic KCs inhibitor, in standard and HF diet administered
Wistar rats.
Materials and methods
Animals and experimental protocol
Male rats were kept in a temperature-controlled room at
a 12:12-h light-dark cycle. Animals had free access to
drinking water and diet if not stated otherwise. All
experiments were performed in agreement with the Ani-
mal Protection Law of the Czech Republic 311/1997
which is in compliance with Principles of Laboratory
Animal Care [27] (NIH Guide to the Care and Use of
Laboratory Animals, 8th edition, 2011) and were
approved by the ethical committee of the Institute for
Clinical and Experimental Medicine. Starting at age 3
months (b.wt. 300 20 g), animals were fed either HF
diet (60 cal% as fat, 20 cal% as protein, 10 cal% as car-
bohydrate) or standard laboratory chow diet (SD) for 4
weeks. The FFA composition of the diet is given in
Additional file 1. The groups designated as SD-starved
or HF-starved were deprived of food for the last 24
hours, the groups labeled SD-fed or HF-fed had free
access to the diet until decapitation (10 - 11 a.m.).
When indicated, fed animals were administered insulin
30 min prior to decapitation (6 U/kg i.p.). Gadolinium
chloride was administered in two doses 72 and 24 hrs
prior to decapitation (10 mg/kg = 0.04 mM/kg i.p.).
Oral glucose tolerance test
An oral glucose tolerance test (OGTT) was performed
on a separate group of animals (n = 4). The rats were
starved overnight and then given a single dose of glu-
cose (3 g/kg b.wt.) per os dissolved in sterile saline.
Blood was taken from the tail vein at 15, 30, 60, 120
and 180 min intervals and glucose was measured by
Accu-check GO glucometer (Roche Diagnostics, Man-
nheim, Germany). Results were expressed as area under
the curve (AUC).
Real-time RT-PCR
The samples of liver tissue were dissected immediately
after decapitation and frozen in liquid nitrogen. Total-
RNA was extracted from tissue samples using Trizol
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reagent (Invitrogen) according to standard protocol [28].
A DNAase step was included to avoid possible DNA
contamination. A standard amount of total RNA (1600
ng) was used to synthesize first-strand cDNA (High
Capacity RNA-to-cDNA kit, Applied Biosystems, Foster
City, CA). RT-PCR amplification mixtures (25 μl) con-
tained 1 μl template cDNA, SYBER Green master mix
buffer (Quanti-Tect, Qiagen, Hilden, Germany) and 400
nM (10 pmol/reaction) sense and antisense primer.
Reactions were run on an Applera 7300 Real-Time PCR
detector (Applied Biosystems). The results were analysed
by SDS software version 2.3 (Applied Biosystems). The
expression of genes of interest was normalised to the
housekeeper gene (Ubc) and calculated using ΔΔCt
method.
Primer design
The primer sets were based upon known rat sequences
available from the Rat Genome database http://www.rgd.
mcw.edu. Primer design was performed with Primer3
software http://www.frodo.wi.mit.edu. Primer character-
istics are listed in Additional file 2.
Preparation of “light” and “dense” lysosomal fractions
The lysosomes and phagolysosomes represent a hetero-
geneous population of organelles. 20% (wt/vol) homoge-
nate was prepared by homogenization of liver tissue in
0.25 M sucrose; 0.001 M EDTA pH = 7.4; heparin 7 IU/
m, 1 mM PMSF, leupeptin 10 μg/ml, aprotinin 10 μg/ml
by Teflon pestle homogenizer. The crude impurities
were removed by brief centrifugation at 850 g. The fat
cake was removed carefully in order to prevent contami-
nation of liquid fraction. The homogenate was centri-
fuged for 10 000 g 20 min 4°C and the resulting pellet
and supernatant were separated. The supernatant con-
tains preferentially the less dense lysosomes with a
higher TAG content ("light lysosomes”), the pellet is
formed by more dense particles ("dense lysosomes”).
Assay of triacylglycerol lipase activity on exogenous
substrate
The optimal conditions for the lipase assay (substrate
concentration, reaction temperature and linear range of
the assay) were determined as described previously [29].
Lysosomal subfractions prepared from the fresh tissue
under iso-osmotic conditions were used for the assay.
The reaction medium (92.5 kBq 3H triolein, 100 μM
triolein, 110 μM lecithin, 0.15 M NaCl, 0.1 M acetate
buffer pH = 4.5) was emulsified by sonication (Hielsler
sonicator UP200S Teltow, Germany). The assay itself
was performed under hypoosmotic conditions (50 mM
sucrose) in order to ensure the release of the enzyme
sequestered within the lysosomes. The liver homogenate
or isolated fractions were incubated for 60 min at 30°C.
The released fatty acids were extracted according to [30]
and counted for radioactivity.
Electrophoretic separation and immunodetection
Liver samples (200 mg) were harvested in situ and
stored in liquid nitrogen until further utilization. The
homogenate was prepared by Ultra-Turax homogenizer
(IKA Worke, Staufen, Germany) in a homogenization
buffer (150 mM NaCl, 2 mM EDTA, 50 mM TRIS, 20
mM glycerolphosphate, 1 mM Na3VO4, 2 mM sodium
pyrophosphate, 1 mM PMSF, leupeptin 10 μg/ml, apro-
tinin 10 μg/ml). The proteins were separated by electro-
phoretic separation under denaturating conditions and
electroblotted to PVDF membranes. The level of phos-
phorylation of PKB kinase and insulin receptor (IR) was
assessed by immunodetection using specific antibodies.
The total expression of PKB and IR protein was deter-
mined on the same membrane after striping and reblot-
ting using specific antibodies. LC3-II content was
determined in the 20% liver homogenate lysed by 2%
SDS at 100°C. The loading control was performed using
rabbit polyclonal antibody to beta actin. The list of anti-
bodies employed in this study is given in Additional file
3. The bands were visualized using ECL and quantified
using FUJI LAS-3000 imager (FUJI FILM, Tokyo, Japan)
and Quantity One software (Biorad, Hercules, CA).
Determination of autophagy intensity
The most frequently used autophagy marker is the
quantification of microtubule-associated protein 1 light
chain 3 (LC3). LC3 is initially synthesized in an unpro-
cessed form, proLC3, which is converted into proteolyti-
cally processed form lacking amino acids from the C-
terminus, LC3-I, and is finally modified into a phospha-
tidylethanolamine-conjugated form, LC3-II. LC3-II is
the only protein marker that is reliably associated with
phagophores, sealed autophagosomes and mature autop-
hagosomes/autolysosomes [31]. The LC3-I and LC3-II
content was determined as described above and the
autophagy intensity was estimated as the LC3-II:LC3-I
ratio.
Determination of DAG content
This method is based on the phosphorylation of DAG in
the sample to DAG-3-phosphate using g35-ATP followed
by quantification of radioactivity in a chlorophorm
extract. Lipids from liver tissue or incubation mixture
were extracted in chloroform/methanol and an aliquot
of chlorophorm phase was evaporated under a stream of
nitrogen. The sample was then solubilised by sonication
in detergent buffer (7.5% n-octyl-b-D-glucopyranoside, 5
mM cardiolipin,1 mM DETAPAC). Reaction buffer (50
mM imidazol/HCl, pH = 6.6, 50 mM NaCl, 12.5 mM
MgCl2, 1 mM EGTA), diacylglycerol kinase and g
35-
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ATP were added and incubated 30 min in 25°C. Lipids
were extracted into chloroform/methanol, phases were
separated with 1% HClO4 and the exact volume of
lower chlorophorm phase was determined. An aliquot
was evaporated, resolved in 5% chloroform/methanol
and separated by TLC. Individual populations of lipids
were visualised by iodine vapours, the bands corre-
sponding to DAG were scraped off and the radioactivity
was determined by scintillation counting.
Biochemical analyses
TAG content in liver homogenate was determined after
the extraction according to Folch [32]. The glycogen con-
tent was determined in homogenate after hydrolysis in
30% KOH and expressed as a glucose equivalent (μmoles
per g wet weight). Protein concentration, FFA, - hydroxy-
butyrare, insulin and TAG serum content were deter-
mined using commercially available kits (protein
concentration: QuantiPro BCA Assay kit, Sigma-Aldrich,
St. Louis, MO; FFA: FFA half micro test, Roche Diagnos-
tics, Mannheim Germany; triglycerides: Pliva-Lachema,
Brno Czech Republic; insulin: Mercodia, Uppsala Swe-
den; hydroxybutyrate: RanBut, RANDOX, Crumlin, UK).
Statistical analysis
Data are presented as mean SEM. Statistical analysis was
performed using Kruskal-Wallis test with multiple com-
parisons (n = 5 -7). Differences were considered statisti-
cally significant at the level of p < 0.05.
Results
Effect of Kupffer cells reduction on lipid and glucose
metabolism
At the end of the experiment, we found no difference in
body weight between experimental groups (table 1). As
expected, the adiposity (expressed as the percent of epi-
didymal fat pad weight of the total body weight) was
higher in HF diet administered group but it was not
affected by the gadolinium treatment. HF diet adminis-
tration significantly affected FFA metabolism and abol-
ished the prandial dependent variation in serum FFA
concentrations. Acute gadolinium treatment (two doses
24 and 72 hrs prior the experiment) had no effect on
weight gain and adiposity (Additional file 4: Table S1).
This resulted in a significant elevation of fed FFA serum
levels in both SD and HF groups. Concentration of
ketone bodies in serum may serve as an indicator of
FFA metabolism in the liver. The fasting concentration
of ketone bodies in serum was similar in all groups.
Both HF diet administration and gadolinium treatment
independently led to the increased ketogenesis in fed
state and their effect was additive. HF diet administered
animals exhibited higher triglyceridemia when compared
to their SD fed littermates. GdCl3 treatment led to a
substantial decrease of plasma TAG in HF group while
having no effect in SD group. Fasting serum glucose was
comparable in all groups. Fasting insulinemia was mod-
erately elevated due to the HF diet feeding and GdCl3
administration significantly exacerbated this trend. As
expected, whole body glucose tolerance determined as
area under the curve (AUC) during the oral glucose tol-
erance test was worsened in HF group compared with
SD fed animals. In the GdCl3 treated HF group, we
observed a trend to the worsening of glucose tolerance
but it did not reached statistical significance (p = 0.063).
Nevertheless, a significant difference was found in the
course of OGTT curve, the glucose concentration in 60
min being significantly higher in HF + GdCl3 when
compared with HF diet-only fed animals. No effects
were observed in SD group. In conclusion, KCs reduc-
tion influenced selected parameters of lipid and glucose
metabolism but only in HF group.
Kupffer cells reduction increases lysosomal degradation
of TAG
As it has been recently shown in hepatocytes, a significant
portion of TAG is degraded in lysosomes in the liver and
the autophagy pathway has been proposed as one of the
mechanisms ensuring the TAG degradation in hepatocytes
[33]. According to this hypothesis, the lipid droplets are
engulfed by autophagolysosomal membrane and trans-
ported via autophagy mechanisms into the lysosomes for
degradation. As it was previously demonstrated [29], these
activated lysosomes are less dense ("light”) and could be
separated from the inactive lysosomal pool ("dense”) by
differential centrifugation [34]. Lysosomal lipase (LAL) is
the only lysosomal lipase and this enzyme is active solely
within the lysosomes. It seems that the critical point in
determining its physiological activity is the transportation
of the substrate (lipid droplets) to the site of degradation
(lysosomes). Based on these assumptions, we tested the
effect of KCs reduction on lysosomal TAG degradation
according to three parameters: 1. the distribution of LAL
activity among the light and dense lysosomes; 2. the distri-
bution of LAL protein among the light and dense lyso-
somes and 3. the autophagy intensity determined as LC3-
II/LC3-I ratio.
As shown on Figure 1A, fasting LAL activity asso-
ciated with light lysosomal fraction (i.e. physiologically
active enzyme) was not influenced by diet. In fed ani-
mals, LAL activity in HF group was elevated by approx.
50% compared to their littermates administered SD.
KCs reduction had a significant stimulatory effect on
LAL activity associated with light lysosomal fraction in
both dietary groups and both in fed and starved animals.
Nevertheless, while in SD-starved, SD-fed and HF
-starved groups this elevation remained in the range of
approx 50%, while this elevation in HF -fed group
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reached more than 200%. In contrast to light lysosomal
fraction, the LAL activity determined in dense lysosomes
was comparable in all groups with the exception of the
GdCl3-treated HF -fed animals where we had observed
an approximate 45% decrease of the enzyme activity
(Figure 1B). As shown in Figure 2, GdCl3 in lower doses
(< 1 mM) had no direct effect on LAL activity in vitro
and in higher doses it even inhibited it. This finding
indicates that the observed effect should be ascribed to
the KCs reduction and not to the artificial stimulation
of the enzyme.
The abundance of LAL protein in the light lysosomal
fraction followed the same trend as the distribution of
LAL activity. As shown on Figure 3, HF diet itself
resulted in the increased LAL protein content in light
lysosomes of the fed animals. The effect of HF diet was
markedly exacerbated by GdCl3 treatment. Similar
results were obtained when we determined the autop-
hagy intensity as the LC3-II/LC3-I ratio in the liver
homogenate (Figure 4). As expected, we observed a sig-
nificant decrease of autophagy intensity in SD-fed com-
pared with the SD-starved animals. HF diet abolished
this regulation by increasing the autophagy intensity
especially in the fed state and this effect was signifi-
cantly accentuated in fed animals of HF + GdCl3 group.
This data shows that the reduction of KCs population is
Table 1 Effect of HF diet and Kupffer cells reduction on lipid and glucose metabolism parameters in serum
SD SD + GdCl3 P HF HF + GdCl3 P
body weight (g) 359 ± 3.4 369 ± 11.2 N.S. 365 ± 6.2 372 ± 8.5 N.S.
adiposity (%) 1.2 ± 0.03 1.4 ± 0.07 N.S. 1.6 ± 0.18x 1.8 ± 0.06 N.S.
s-FFA
(mmol/l)
starved 0.8 ± 0.1 0.81 ± 0.04 N.S. 0.54 ± 0.04x 0.46 ± 0.01y N.S.
fed 0.27 ± 0.02 0.43 ± 0.02 0.01 0.5 ± 0.03x 0.67 ± 0.02y 0.01
s-ketone bodies
(mmol/l)
straved 3.1 ± 0.1 3.2 ± 0.1 N.S. 3.1 ± 0.2 2.8 ± 0.4 N.S.
fed 0.16 ± 0.02 0.34 ± 0.01 0.01 0.5 ± 0.05x 1.2 ± 0.2y 0.001
s-TAG (mmol/l) fed 1.1 ± 0.1 1.0 ± 0.1 N.S. 2.0 ± 0.3x 0.8 ± 0.1 0.001
s-glucose (mmol/l) starved 4.3 ± 0.2 4.7 ± 0.3 N.S. 4.6 ± 0.3 4.6 ± 0.2 N.S.
s-insulin
(ng/l)
starved 112 ± 6 125 ± 8 N.S. 126 ± 10x 161 ± 8y 0.05
fed 544 ± 29 474 ± 37 N.S. 472 ± 18 467 ± 12 N.S.
OGTT AUC180 min 1168 ± 27 1094 ± 41 N.S. 1305 ± 29
x 1370 ± 15y 0.063
OGTT glucose 60 min, mM 6.5 ± 0.2 6.4 ± 0.24 N.S. 8.7 ± 0.3x 9.5 ± 0.21y 0.05
Fasted animals were deprived of food for 24 hours, fed animals had free access to food. Adiposity was expressed as the ratio of epididymal fat pad weight to the
total body weight [(EWAT/b.wt.)*100]. OGTT = oral glucose tolerance test; AUC = cumulative area under the curve for blood glucose over 180 min. P value
indicates the significance of GdCl3 treatment within each group;
x p < 0.05 HF vs SD; y p < 0.05 HF + GdCl3 vs SD + GdCl3. Data are given as mean ± S.E.M., n =
6; OGTT n = 4.
Figure 1 Effect of HFdiet and Kupffer cells reduction on lysosomal lipase activity measured as FFA release from artificial substrate
(3H-triolein). A: light lysosomes; B: dense lysosomes. The lipase activity was measured as the release of fatty acids at pH = 4.5 from3H triolein.
All data are presented together with median. Open symbols = starved animals (S); closed symbols = fed animals (F). ○ ● SD; □ ■ SD + GdCl3; ♦
◊ HF; ▲ Δ HF + GdCl3. # p < 0.05 SD + GdCl3vs SD; *p < 0.05, *** p < 0.001 HF + GdCl3 vs HF; xp < 0.05 HF vs SD.
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associated with the increased lysosomal lipolysis of liver
TAG and suggests the possibility that an increased
autophagy may underlay the observed pro-lypolitic
effect.
Kupffer cells reduction increases the formation of TAG
metabolism intermediates in the liver
KCs reduction was associated with lower TAG content in
the liver of the HF group (table 2) and with increased
ketogenesis (table 1) which provides further indirect evi-
dence supporting the stimulatory effect of GdCl3 treat-
ment on TAG liver degradation. The increased TAG
breakdown may be associated with the increased forma-
tion of TAG degradation products. As shown in table 2,
GdCl3 treatment significantly elevated DAG content in HF
group exacerbating the effect imposed by HF diet itself.
No changes in liver TAG and DAG content due to the
GdCl3 administration were observed in the SD group.
Taken together, our data suggest that in steatotic liver
KCs reduction leads to the increased production of poten-
tially hazardous lipid metabolism intermediates like DAG.
Kupffer cells reduction exacerbates the manifestation of
HF diet induced hepatic insulin resistance
HF diet administration is associated with rapid onset of
hepatic insulin resistance [35]. In our experiments, four
weeks of HF diet administration resulted in attenuation
of insulin-stimulated PKB and insulin receptor phos-
phorylation (Figure 5) and in the significant diminution
of insulin-stimulated liver glycogenesis (table 3). Abla-
tion of KCs had no effect on hepatic insulin sensitivity
in the SD group but it severely exacerbated insulin resis-
tance in the liver in HF diet administered animals. We
detected virtually no effect of insulin on PKB phosphor-
ylation and only very mild insulin-stimulated phosphor-
ylation of insulin receptor on tyrosine. The insulin-
stimulated glycogenesis was decreased compared with
the untreated HF group. These results indicate that KCs
depletion is associated with the further deterioration of
hepatic insulin sensitivity already provoked by HF diet.
Kupffer cells reduction combination with HF diet is
associated with the increase in PKCε activity
PKCε has been implicated as a key player in the onset of
HF diet-induced hepatic insulin resistance. PKCε activa-
tion is reflected by its translocation from cytosol to the
plasma membrane and we used the ratio of relative
abundance of PKCε in the membrane and cytosol frac-
tions as the parameter indicating PKCε activity. As
shown in Figure 6, in animals fed SD PKCε total mem-
brane/cytosol ratio is not influenced by GdCl3 adminis-
tration. HF diet itself led to the increased translocation
Figure 2 Effect of GdCl3 on lysosomal lipase activity in vitro. The GdCl3 was added to the sample 15 min prior the start of the assay; the
lipase activity was measured as the release of fatty acids at pH = 4.5 from 3H triolein. Data represent an average from three independent
experiments.
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of PKCε to the total membrane fraction. Reduction of
KCs population was associated with a marked increase
of PKCε abundance in total membranes at the expense
of its content in the cytosol.
HF diet does not lead to the expansion of hepatic Kupffer
cell population but increases the expression of alternative
activation pathway markers
The levels of two macrophage markers, CD68 and Emr-
1 (F4/80), were used to assess the size of the resident
macrophage population in the liver. The expression of
either of these two markers remained unaltered due to
the HF diet feeding compared with SD group. The
expression of TNFa, classical (pro-inflammatory) activa-
tion pathway marker, was not affected in the HF group.
In contrast to this, the alternative pathway was signifi-
cantly activated in the liver of animals fed HF diet as
demonstrated by the increase of the expression of Arg-
1, Mrc-1 and IL-10 (Figure 7A). Gadolinium administra-
tion led to the approx 60% and 70% reduction of CD 68
and Emr-1 expression, resp., and this reduction was not
dependent on the diet (Figure 7B and 7C). In the SD
group, the expression of classical pro-inflammatory acti-
vation markers was decreased while the alternative acti-
vation was not significantly influenced by this treatment.
In contrast, in the HF group, GdCl3 treatment resulted
in a significant increase of the expression of IL-1b and
TNFa and to a significant decrease of the expression of
Arg-1, Mrc-1 and IL-10 mRNA. Taken together, our
data reveals that administration of HF diet rich in
Figure 3 Effect of HF diet and Kupffer cells reduction on lysosomal lipase protein abundance in light lysosomal fraction. Lysosomal
lipase can degrade intracellular TAG only when lipid droplets and LAL co-localize in autophagolysosomes. Autophagolysosomes “light”
lysosomes) are less dense than inactive lysosomes due to their content of less denselipid droplets and could be separated by differential
centrifugation. The light lysosomal fraction was prepared as described in Material and Methods. All data are presented together with median.
Open symbols = starved animals (S); closed symbols = fed animals (F). ○ ● SD; □ ■ SD + GdCl3; ♦ ◊ HF;▲ Δ HF + GdCl3.†p < 0.05,† †p < 0.01,† †
†p < 0.001 fed vs starved; ** p < 0.01, *** p < 0.001 HF + GdCl3 vs HF.
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MUFA itself results in alternative activation of liver
macrophages. Furthermore, the reduction of the KCs
population by gadolinium treatment resulted in a drastic
reduction of alternatively activated population of liver
macrophages and to a significant up-regulation of the
expression of classical, i.e. pro-inflammatory markers in
steatotic liver. No such effect was observed in the SD
group.
Figure 4 Effect of HF diet and Kupffer cells reduction on autophagy intensity determined as LC3-II expression in the liver. During the
autophagosome formation, cytosolic LC3-I protein is lipidated to form LC3-II. LC3-II is incorporated into autophagosome membrane and remains
there during the whole autophagy process until the stage of late lysosome. The formation of LC3-II is thus considered to be an indicator of
autophagy intensity. The quantification of LC3-I and LC3-II in liver homogenate was performed by immunodetection. Data are expressed as LC3-
II/LC3-I ratio. All data are presented together with median. Open symbols = starved animals (S); closed symbols = fed animals (F). ○ ● SD; □ ■
SD + GdCl3; ♦ ◊ HF;▲ Δ HF + GdCl3. † †p < 0.01, † † †p < 0.001 fed vs starved;#p < 0.5 SD + GdCl3 vs SD; *** p < 0.001 HF + GdCl3 vs HF; xxxp <
0.001 HF vs SD.
Table 2 Effect of HF diet and Kupffer cells reduction on triacylglycerol content in the liver
SD SD + GdCl3 P HF HF + GdCl3 P
TAG (μmol/g) fasted 7.1 ± 0.2 8.1 ± 0.4 N.S. 21.4 ± 1.4x 14.1 ± 1.7y 0.05
fed 4.4 ± 0.4 5.3 ± 0.4 N.S. 25.2 ± 0.7x 16.4 ± 0.3y 0.01
DAG (nmol/g) fasted 10.8 ± 0.3 12.4 ± 0.6 N.S. 31.2 ± 1.1x 54.6 ± 2.5y 0.01
fed 7.3 ± 0.2 6.8 ± 0.2 N.S. 36.7 ± 1.8x 69.3 ± 2.1y 0.001
P value indicates the significance of GdCl3 treatment within each group;
x p < 0.05 HF vs SD; y p < 0.05 HF + GdCl3 vs SD + GdCl3. Data are given as mean ± S.E.
M., n = 6.
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Discussion
In the present study, we provide evidence that KCs
under certain circumstances play a protective role in the
development of steatosis-induced insulin resistance. Our
conclusion is based on several findings. A HF diet rich
in MUFA is associated with a shift towards alternative
rather than classical activation pathway of macrophages.
In the steatotic liver, the reduction of KCs population
by GdCl3 negatively affected alternatively activated
macrophages and enhanced the expression of pro-
inflammatory markers TNFa and IL-1b It was further
associated with a significant increase of autophagy, lyso-
somal lipolysis, increased production of potentially
hazardous TAG metabolism intermediates (DAG) and
PKCε activation in the liver. Finally, the KCs reduction
resulted in a significant exacerbation of HF diet-induced
hepatic insulin resistance.
It has been recognized that KCs fulfill a dual role -
they may function either as mediator of damage or as a
protector during processes of regeneration and repair
[36]. Strategies employing depletion or modulation of
KCs, such as application of gadolinium chloride or lipo-
some-encapsulated dichloromethylene bisphosphonate
(Cl2-MBP) were effective to protect against liver injury
induced by thioacetamide [37], carbon tetrachloride
[38], alcohol [39] and ischemia/reperfusion [40]. On the
other hand, there are clear indications that KCs can
mediate protection and that their depletion increases
liver injury after hepatectomy [41] or after total hepatic
ischemia/reperfusion injury with bowel congestion [42].
Nevertheless, the role of KCs in the modification of
metabolic fitness of the liver remains enigmatic. Several
recent studies explored the role of KCs in relation to
hepatic steatosis and insulin resistance which reported
Figure 5 Effect of HF diet and Kupffer cells reduction on insulin signalling. A: PKB (Ser473) phosphorylation, B: insulin receptor (phospho
Y1158) phosphorylation. The results are expressed as fold increase in the insulin-stimulated state relative to the basal state. Representative
Western blot is shown above each graph. The basal level of PKB-and IR-phosphorylation was determined in the homogenate prepared from the
liver of 24 hours starved animals. The effect of insulin was determined in identically processed samples from animals which had free access to
food and 30 min prior to decapitation were administered insulin 6 U/kg. The total PKB and IR expression was determined after striping the
membranes and re-blotting with anti-PKB and anti-IR antibodies, resp. All data are presented together with median. gray ○ SD; gray □ SD +
GdCl3; gray ◊ HF; gray Δ HF + GdCl3. *** p < 0.001 HF + GdCl3 vs HF;
x p < 0.05, xx p < 0.01 HF vs SD.
Table 3 Effect of HF diet and Kupffer cells reduction on glycogen content in the liver
SD SD + GdCl3 P HF HF + GdCl3 P
glycogen (μmol/g) starved 12 ± 2.6 65 ± 8.5 0.01 17 ± 1.6 49 ± 8 0.05
fed + ins 226 ± 13 196 ± 13 N.S. 198 ± 19 110 ± 18 0.01
Animals in “fed + ins” group were provided food ad libitum and 30 min prior decapitation were administered insulin (6 U/kg b.wt.) i.p. The glycogen is expressed
in glucose equivalents (μmoles per g wet weight) P value indicates the significance of GdCl3 treatment within each group;
y p < 0.05 HF + GdCl3 vs SD + GdCl3.
Data are given as mean ± S.E.M., n = 6.
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conflicting results since KCs depletion has been asso-
ciated both with improvement [23] or worsening [43] of
hepatic insulin resistance. Unfortunately, the described
experiments vary greatly in experimental design which
may profoundly influence the conclusions drawn from
these studies. We can identify several “areas of disagree-
ment” in this field.
In contrast to adipose tissue, the literature is not uni-
form about the effect of HF diet on the macrophage
infiltration into liver. Some studies [25,44,45] report a
slight increase in liver macrophages but most of the
authors found no macrophage infiltration in response to
HF diet [23,46-48]. In our study, we found no changes
either in CD68 or Emr1 expression in HF diet adminis-
tered animals compared with the SD group. Similarly,
quite opposite results were reported when the activation
status of liver macrophages was concerned. Classical (i.e.
proinflammatory) activation was reported after 2 weeks
of HF diet based on milk fat [43] containing approx.
70% of SFA and 1-5% of trans FA, or after 3 days of HF
diet containing lard [25]. The later data are derived
from a 3-day diet administration which indicates the
existence of early inflammatory phase that occurs during
the first days of HF diet administration and may contri-
bute to the rapid onset of hepatic insulin resistance.
Nevertheless, with the increasing duration (15 wks) of
feeding HF diet containing MUFA (lard), the alternative
activation of KCs prevails and imposes the immune-tol-
erant, anti-inflammatory state of the liver [16]. This
could be considered as an adaptive mechanism counter-
acting the negative influence of a HF diet. Recent evi-
dence shows that an important factor driving the switch
between pro- and anti-inflammatory programs of resi-
dent macrophages may be the composition of dietary fat
and, depending on the fatty acid composition, the effect
may be highly variable; the pro-inflammatory potential
Figure 6 The effect of HF diet and Kupffer cells reduction on PKCε activation in the liver. Representative Western blot is shown in the
upper part of the figure. The PKCε activation was assessed according to its translocation from cytosolic to membrane fraction and expressed as
the ratio of relative densities of the bands in the membrane fraction and the corresponding ones in cytosolic fraction. All data are presented
together with median. gray ○ SD; gray □ SD + GdCl3; gray ◊ HF; gray Δ HF + GdCl3. xxp < 0.01 SD vs HF; *** p < 0.001 HF + GdCl3 vs HF.
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Figure 7 Effect of HF diet and Kupffer cells reduction on macrophage classical and alternative activation markers. A: HF vs SD group; B:
SD + GdCl3 vs SD group; C: HF + GdCl3 vs SD group. GdCl3 was administered in two doses 72 and 24 hrs prior the experiment (10 mg/kg, i.p.).
The expression of individual macrophage markers mRNA was determined by RT-PCR. Data are expressed as fold change related to untreated SD
group with expression in standard diet (SD) arbitrary set at 1 (dotted line). gray ○ SD; gray □ SD + GdCl3; gray ◊ HF; gray Δ HF + GdCl3. xxp <
0.01 SD vs HF; #p < 0.05, ### p < 0.001 SD + GdCl3 vs SD; *p < 0.05, **p < 0.01, ***p < 0.001 HF + GdCl3 vs HF.
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is attributed to SFA while MUFA and PUFA exhibit an
inhibitory effect on Toll like receptors-dependent
inflammatory pathway and rather stimulate alternative
activation. Shi et al. [47] demonstrated that SFA (parti-
cularly C14:0, C16:0 and C18:0) stimulated TNFa and
IL-6 production from RAW246.7 macrophage cell line
while no stimulation was observed after treatment with
MUFA or PUFA fatty acids. Pretreatment of RAW 264.7
macrophages with palmitate resulted in their pro-
inflammatory activation and the conditioned palmitate-
free medium from these macrophages which was cap-
able of inducing insulin resistance in myoblasts [49,50].
Wen et al. [51] reported that saturated fatty acid (palmi-
tate) but not unsaturated fatty acid (oleate) induced
NLRP3-ASP inflammasome activation in hematopoietic
cells. In contrast, PUFA (especially EPA and DHA)
treatment ameliorated LPS-induced pro-inflammatory
signaling in macrophages and enhanced the insulin sen-
sitivity of 3T3L1 adipocytes in co-culture experiments
[52,53]. We have previously shown that 4 wks adminis-
tration of the diet rich in trans FA (60 cal% fat; 50% of
fat in the form of trans MUFA) resulted in a highly sig-
nificant elevation of TNFa and IL-1b expression in the
liver [54].
In our experiments, quantitative RT-PCR revealed that
4 weeks of administration of the HF diet rich in MUFA
led to the increased expression of arginase-1, manose
receptor and IL-10 which indicates the alternative acti-
vation of liver macrophages. In contrast to this, we did
not find any sign of the increased pro-inflammatory sig-
naling. Interestingly, in HF group, the reduction of KCs
population by GdCl3 significantly down-regulated the
expression of alternative macrophage markers (Arg1,
Mrc1) and KCs derived protective cytokine (IL-10)
while increasing the expression of pro-inflammatory
TNFa and IL-6. We hypothesize that the observed
increase in these markers in the liver may reflect the
infiltration of macrophages from circulation which have
already been pro-inflammatory activated, i.e. in adipose
tissue. Much less of an effect was observed in SD admi-
nistered animals.
It has been demonstrated that KCs depletion either
ameliorates [23] or aggravates [25,43] hepatic insulin
resistance. The above mentioned observation (the
change of the relative abundance of the anti- and pro-
inflammatory activated macrophages) may provide the
explanation for the different results obtained after acute
and chronic GdCl3 activation. The acute KCs reduction
has different effects on hepatic insulin resistance
induced by HF diets with different fat composition. HF
diet rich in trans FA with high inflammation-stimulating
potential evoked severe hepatic insulin resistance and
the short-term KCs reduction failed to induce any
changes in it, either positive or negative [54]. We
explain this by the persisting TNFa expression in the
liver as we were not able to completely eliminate classi-
cally activated macrophages (TNFa liver expression: pre
GdCl3 31.3 fold over SD; post GdCl3 10 fold over SD).
In contrast, HF diet rich in MUFA with low inflamma-
tory potential elicited less pronounced hepatic IR but
the IR symptoms which were exacerbated by short-term
GdCl3 application. Neyrinck [26] using a similar diet (60
cal% as fat, lard) showed that 4 weeks of chronic GdCl3
administration resulted in the enhanced whole-body and
hepatic insulin sensitivity. Nevertheless, chronically
administered GdCl3 mice exhibited markedly reduced
weight gain on the high fat diet. Improved insulin sensi-
tivity and glucose tolerance in gadolinium treated mice
could be due to the decreased weight gain independent
of KCs function.
A highly controversial issue is the effect of KCs on
hepatic steatosis. KCs have been shown to promote stea-
tosis [43], to reduce steatosis [23] or to have no effect
on it [55]. Interestingly, in our experiments, KCs deple-
tion led to a concomitant reduction of liver TAG con-
tent. This finding is rather surprising as it has been
repeatedly confirmed that ectopic TAG accumulation in
the liver is associated with the development of insulin
resistance. Nevertheless, studies carried out on a mice
model of liver diacylglycerol acyltransferaze-2 overex-
pression exhibiting severe steatosis but normal hepatic
insulin sensitivity [56] showed that steatosis per se could
be dissociated from the onset if hepatic insulin resis-
tance. According to the currently accepted hypothesis,
inert TAG molecule itself probably does not interfere
with insulin signaling but the negative effects of steatosis
are mediated rather by bioactive intermediates of lipid
metabolism like DAG or Lc-AcCoA [57]. This hypoth-
esis is in line with our observation that KCs depletion is
associated not only with hepatic insulin resistance but
also with significantly accentuated lipolysis and an
increased DAG content.
The exact mechanism of the beneficial effect of alter-
natively activated macrophages on the metabolism of
fatty hepatocytes is still a matter of debate. It has been
proposed that alternatively activated macrophages may
attenuate tissue inflammation by paracrine action which
leads to the improved insulin signaling [6,58]. Another
hypothesis proposes that alternatively activated macro-
phages may secrete trophic factors that act in a para-
crine or endocrine manner to enhance oxidative
metabolism in peripheral tissues [6]. Our data indicates
the existence of another mechanism of KCs influence
on hepatocytes. In our study, we saw that the reduction
of KCs population by GdCl3 resulted in a shift towards
pro-inflammatory activation with a concomitant
decrease of alternative activation. As has been recently
shown, pro-inflammatory cytokines, in particular TNF-
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a, IL-1, IL-2 and IL-6, stimulate autophagy while cyto-
kines produced by alternatively activated KCs, Il-4, IL-
10 and IL-13, are inhibitory [59]. We suggest that the
reduction of alternatively activated, IL-10 producing
macrophages results in the enhancement of autophagy
and consequent stimulation of lysosomal lipolysis. This
effect could be further potentiated by the increased pro-
duction of pro-autophagic cytokines like TNFa. In our
experiments we observed that the reduction of KCs
population resulted in highly significant increase of lyso-
somal TAG degradation in the steatotic, but not in the
normal, liver. The main products of lysosomal lipase
action on the TAG molecule are 1,2-sn-DAG and one
molecule of fatty acid while the degradation to monoa-
cylglycerol or glycerol and FFA is negligible [60]. 1,2-sn-
DAG is an important intracellular signaling molecule
and it is the known activator of PKCε [61]. Recently, it
has been shown that fat-induced hepatic insulin resis-
tance may result from activation of PKCε and its down-
stream targets [35,62]. Nevertheless, the source of DAG
remained unidentified. The increased DAG content due
to the increased flux through TAG synthetic pathway
and the following PKCε activation was described in HF
diet-fed animals [63]. However, DAG is also an interme-
diator in the TAG degradation pathway that is accentu-
ated after GdCl3 treatment. Our findings suggest that
DAG originating from the increased lipolysis could act
as a PKCε activator and contributes to the worsening of
hepatic insulin sensitivity after KCs reduction.
Conclusions
We found that a HF diet rich in MUFA triggers the
alternative activation program in KCs. In the steatotic
liver, a reduction of the KCs population was associated
with a decrease of alternative activation and with a shift
towards the expression of pro-inflammatory activation
markers, with the increased autophagy, elevated lysoso-
mal lipolysis, increased formation of DAG, PKCε activa-
tion and marked exacerbation of HF diet-induced
hepatic insulin resistance. We propose that in the pre-
sence of high MUFA content, the population of alterna-
tively activated resident liver macrophages may mediate
the beneficial effects on liver insulin sensitivity and alle-
viate the metabolic disturbances imposed by a HF diet
feeding and steatosis.
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